|
|||||
|
|
Hypoxia positron emission tomography imaging with 18f-fluoromisonidazole |
|
| Authors: | Lee Sze Ting Scott Andrew M |
| Affiliation: | aCentre for PET, Austin Health, Heidelberg, Victoria, Australia. bLudwig Institute for Cancer Research, Austin Hospital, Heidelberg, Victoria, Australia. cDepartment of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia. |
| Abstract: | The importance of hypoxia in disease pathogenesis and prognosis is gathering increasing clinical significance and having a greater impact on patient management and outcome. Previous efforts to evaluate hypoxia have included the invasive assessment of hypoxia with immunohistologic and histographic oxygen probes. The emergence of new radiotracers has allowed noninvasive assessment of hypoxia, with the most extensively investigated and validated positron emission tomography radiotracer of hypoxia to date being (18)F-fluoromisonodazole ((18)F-FMISO). This review discusses the relevance and biology of hypoxia in cells and organ systems, and reviews the laboratory and clinical applications of (18)F-FMISO in oncology and noncancer disease states. |
| Keywords: | |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ | |